Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Hungary Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20121
20132
20144
20151
20171
20181
20201
20213
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Pfizer2
Seagen Inc.2
Amgen1
Genzyme, a Sanofi Company1
Novartis Pharmaceuticals1
Sierra Oncology LLC - a GSK company1
Sunesis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases18
Bone Marrow Diseases9
Myeloproliferative Disorders6
Lymphoma, Non-Hodgkin5
Polycythemia Vera5
Anemia4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, B-Cell4
Primary Myelofibrosis4
Hemorrhagic Disorders3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.